Log in to save to my catalogue

Effectiveness and Safety of Anakinra for Management of Refractory Pericarditis

Effectiveness and Safety of Anakinra for Management of Refractory Pericarditis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1718075358

Effectiveness and Safety of Anakinra for Management of Refractory Pericarditis

About this item

Full title

Effectiveness and Safety of Anakinra for Management of Refractory Pericarditis

Publisher

United States: Elsevier Inc

Journal title

The American journal of cardiology, 2015-10, Vol.116 (8), p.1277-1279

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

Recurrent pericarditis is a debilitating condition that can be recalcitrant to conventional therapy with nonsteroidal anti-inflammatory agents, colchicine, and glucocorticoids. The aim of this study was to evaluate the therapeutic role of the recombinant interleukin-1 receptor antagonist anakinra in a series of adult patients with recurrent pericar...

Alternative Titles

Full title

Effectiveness and Safety of Anakinra for Management of Refractory Pericarditis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1718075358

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1718075358

Other Identifiers

ISSN

0002-9149

E-ISSN

1879-1913

DOI

10.1016/j.amjcard.2015.07.047

How to access this item